Table 5.

Logistic regression model for factors associated with microbiologically documented bacteremia during postremission treatment

			Multivariate analysis
	n	No. of events	aOR	95% CI	P
HDAC regimen
HDAC-123	91	33	1	—	—
HDAC-135	129	62	1.28	0.69-2.38	.43
Prophylactic G-CSF*
Standard G-CSF	49	27	1	—	—
Pegylated G-CSF	171	68	0.46	0.23-0.90	.02
No. of HDAC cycles
1	27	6	1	—	—
2	68	27	2.71	0.94-7.79	.06
3	125	62	4.11	1.50-11.21	<.01

*Prophylactic G-CSF during first cycle of HDAC.